看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
' }: x* A6 ?4 M3 |; B- H& L a2 l! |7 d
) @8 b# h8 Y( \4 Q& @6 ~1 Q9 gCurrently available feasibility data for possible combination strategies.
) A# s0 w3 t4 I. x5 i" M3 [————————————————————————————————
% H+ `2 v7 a# s7 U, xCombination Feasibility according to preliminary data 1 E0 H0 s9 C7 s# m: }7 E% C7 c
——————————————————————————————————5 `7 P* K& u+ B! ]1 ^* `
Bevacizumab + sorafenib Yes, reduced dose 2 c. ^9 O4 U" O8 ~
Bevacizumab + sunitinib† No
6 v" a7 [ U1 T9 ]0 FBevacizumab + temsirolimus Yes
& o+ J7 S( f" Q ^" kBevacizumab + everolimus Yes 9 f4 r' B0 O* `8 m
Sorafenib + sunitinib ?
' G l# k7 I$ o# tSorafenib + temsirolimus Yes, reduced dose
! ~" W, r; @5 N$ D9 ^Sorafenib + everolimus Yes, reduced dose 7 u3 l" L# F( ~( U Z
Sunitinib + temsirolimus† No
5 d6 X9 u/ F7 h+ z8 vSunitinib + everolimus ?
; `4 @2 Y6 E4 ]& Z" kTemsirolimus + everolimus ? . G `5 l% S7 e/ }( Y1 B
————————————————————
" q( X0 ?' `7 I/ Q1 A: v, I. Q†Led to US FDA warning.
8 a7 L& X: a# I7 ??: As yet unattempted combination.& s7 h$ }& L l+ a$ a
|